The application of comprehensive genomic methodology has successfully identified the presence of frequently mutated genes, including CREBBP (15–17%), Rbl2, MYC, EP300, FRFR1, and PLCG2, in tumors of patients diagnosed with SCLC. Here, EP300 is linked to small cell lung carcinoma.